Cargando…

Treatment selection and experience in multiple sclerosis: survey of neurologists

BACKGROUND: Multiple sclerosis (MS) is a complex disease with many therapeutic options. Little is known about how neurologists select particular disease-modifying therapies (DMTs) for their patients. OBJECTIVE: To understand how neurologists make decisions regarding the prescription of DMTs for pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanson, Kristin A, Agashivala, Neetu, Wyrwich, Kathleen W, Raimundo, Karina, Kim, Edward, Brandes, David W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979792/ https://www.ncbi.nlm.nih.gov/pubmed/24729689 http://dx.doi.org/10.2147/PPA.S53140

Ejemplares similares

A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod
por: Hanson, Kristin A, et al.
Publicado: (2013)

Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study
por: Agashivala, Neetu, et al.
Publicado: (2013)

Treatment adherence in multiple sclerosis: a survey of Belgian neurologists
por: Decoo, Danny, et al.
Publicado: (2015)

Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity
por: Raimundo, Karina, et al.
Publicado: (2013)

Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment
por: Visser, Leo H, et al.
Publicado: (2016)

Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment
por: Kumar, Jinender, et al.
Publicado: (2021)

Multiple sclerosis and pregnancy; What a neurologist may be asked for?
por: Siroos, Bahaadin, et al.
Publicado: (2014)

Neurologists’ views on patient reported outcomes in multiple sclerosis care
por: Reitzel, Signe Baattrup, et al.
Publicado: (2022)

Current Updates on the Diagnosis and Management of Multiple Sclerosis for the General Neurologist
por: Baskaran, Archit B, et al.
Publicado: (2023)

Patient Expression of Emotions and Neurologist Responses in First Multiple Sclerosis Consultations
por: Del Piccolo, Lidia, et al.
Publicado: (2015)

Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists
por: Saposnik, Gustavo, et al.
Publicado: (2018)

Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists
por: Ysrraelit, Maria C., et al.
Publicado: (2018)

Assessment of sexual dysfunction in patients with multiple sclerosis: a perspective from neurologist
por: Gaviria- Carrillo, Mariana, et al.
Publicado: (2022)

Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices
por: Mateen, Farrah J., et al.
Publicado: (2020)

Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists
por: Marfia, Girolama Alessandra, et al.
Publicado: (2022)

The role of glatiramer acetate in the early treatment of multiple sclerosis
por: Brandes, David W
Publicado: (2010)

The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States
por: Solomon, Andrew J, et al.
Publicado: (2021)

When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis
por: Kachuck, Norman J
Publicado: (2011)

Large-scale cross-sectional online survey on patient-neurologist communication, burden of disease assessment and disease monitoring in people with multiple sclerosis
por: Christ, Monika, et al.
Publicado: (2023)

Effect of an Educational Intervention on Therapeutic Inertia in Neurologists With Expertise in Multiple Sclerosis: A Randomized Clinical Trial
por: Saposnik, Gustavo, et al.
Publicado: (2020)

Alienist and Neurologist
Publicado: (1881)

Alumist and Neurologist
Publicado: (1881)

Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening
por: Phillips, Glenn A, et al.
Publicado: (2014)

Analysis of the psychometric properties of the Multiple Sclerosis Impact Scale-29 (MSIS-29) in relapsing–remitting multiple sclerosis using classical and modern test theory
por: Bacci, ED, et al.
Publicado: (2016)

Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS)
por: Saposnik, Gustavo, et al.
Publicado: (2017)

Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study
por: Bergvall, Niklas, et al.
Publicado: (2014)

Psychiatrists, Neurologists and the Neurosurgeon
por: Cushing, Harvey
Publicado: (1935)

The Training of the Neurologist and the Psychiatrist
Publicado: (1937)

An Eighteenth Century Neurologist
por: Comrie, John D.
Publicado: (1925)

Well‐being on supportive techniques in amyotrophic lateral sclerosis: from neurologists' perspective
por: Barć, Krzysztof, et al.
Publicado: (2022)

E-learning preferences of European junior neurologists—an EAYNT survey
por: Sztriha, Laszlo K., et al.
Publicado: (2012)

Knowledge and attitudes of neurologists toward epilepsy surgery: an Italian survey
por: Casciato, Sara, et al.
Publicado: (2022)

Palliative sedation in amyotrophic lateral sclerosis: results of a nationwide survey among neurologists and palliative care practitioners in Germany
por: Salzmann, Laura, et al.
Publicado: (2022)

Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial
por: Calkwood, Jonathan, et al.
Publicado: (2014)

Caught in a no-win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists – a qualitative study
por: Driedger, S. Michelle, et al.
Publicado: (2017)

Diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy in clinical practice: A survey among Dutch neurologists
por: Broers, Merel C., et al.
Publicado: (2020)

Discussing sexuality with Parkinson’s disease patients: a multinational survey among neurologists
por: de Rooy, F. B. B., et al.
Publicado: (2019)

Discussing sexuality with patients with Parkinson’s disease: a survey among Dutch neurologists
por: van Hees, Petra J. M., et al.
Publicado: (2016)

Demographics and management of outpatient concussion visits among neurologists and non-neurologists: 2006–2016
por: Asselin, Patrick D, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qru2i7buvt2vv0c2rt7qvoo8v7